Lilly to Acquire Avid Radiopharmaceuticals

Post date: 2010/11/8 下午 04:10:11

Indianapolis, IN and Philadelphia, PA -Eli Lilly and Company (NYSE: LLY) today announced that it has signed a definitive merger agreement to acquire Avid Radiopharmaceuticals, Inc., a privately held company developing novel molecular imaging compounds intended for the detection and monitoring of chronic human diseases.

More details please see: